EE
Eslam A. Elghonaimy

Publications (1)

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Article scientifique · 2017

Domaines principaux

Sciences de la vie et biotechnologies1

Statistiques

Consultations2
Téléchargements0